Clearside Biomedical shares fall 2.17% intraday as Piper Sandler Companies acquires G Squared Capital Partners.

martes, 5 de agosto de 2025, 10:05 am ET1 min de lectura
CLSD--
Clearside Biomedical, Inc. declined 2.17% in intraday trading. The news event related to Piper Sandler Companies acquiring G Squared Capital Partners, a boutique investment bank specializing in government services and defense technology, does not directly impact Clearside Biomedical, Inc. Therefore, the cause of the stock's decline is not explicitly clear from the given news events.

Clearside Biomedical shares fall 2.17% intraday as Piper Sandler Companies acquires G Squared Capital Partners.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios